| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |